COMMUNIQUÉS West-GlobeNewswire

CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy

25/04/2025 - 16:17

Recommendation is based on Phase 3 EPIDYS trial data that demonstrated Duvyzat (givinostat) provides statistically and clinically meaningful treatment benefits in individuals with Duchenne muscular dystrophy (DMD) If [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

25/04/2025 - 16:20

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 25 April 2025 at 17.20 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

2024 Annual Report Vistin Pharma ASA

25/04/2025 - 16:40

Oslo, Norway, 25 April 2025 Please find attached the Annual Report for 2024 for Vistin Pharma ASA (VISTN). There are no material changes in the financial statements compared to the preliminary full year results [...]

Mental Health Nonprofit Queer LifeSpace to Host Annual Fundraising Gala "Pride Renaissance: Celebrating Community Resilience"

25/04/2025 - 17:19

Biggest fundraising gala in organization’s history aims to raise $75,000 for accessible, queer-affirming mental health care SAN FRANCISCO, April 25, 2025 (GLOBE NEWSWIRE) -- In the midst of a worsening mental health [...]

My Grief Angels Inc Launches Mother's Day "Bouquet of Support" for Grieving Moms

25/04/2025 - 17:25

A Compassionate Mother's Day Initiative for Mothers Grieving THE WOODLANDS, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- As Mother's Day approaches, My Grief Angels Inc, a renowned 501(c)(3) public charity, is extending a [...]

Press release: Transparency Notification from Shareholders

25/04/2025 - 18:00

Transparency Notification from Shareholders Ghent, Belgium – 25 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]

Le Parlement est en pleine campagne « poil » itique : Le vote est ouvert pour le concours photo « Les animaux de compagnie les plus mignons sur la Colline du Parlement »

25/04/2025 - 18:00

OTTAWA, 25 avr. 2025 (GLOBE NEWSWIRE) -- L’Institut canadien de la santé animale (ICSA) est ravi d’annoncer que le vote du public est maintenant ouvert pour le 3e concours annuel de photos « Les animaux les plus mignons [...]

Parliament Gets Paw-litical: Voting Open for Cutest Pets on Parliament Hill Photo Contest

25/04/2025 - 18:00

OTTAWA, April 25, 2025 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is thrilled to announce that public voting is now open for the 3rd Annual Cutest Pets on Parliament Hill photo contest! Canadians [...]

Juvent Launches Next Generation Bone Health Supplement HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Symposium in Washington, DC

25/04/2025 - 18:04

OOLTEWAH, Tenn., April 25, 2025 (GLOBE NEWSWIRE) -- Juvent, an innovator in clinically validated bone and musculoskeletal health solutions, debuted its revolutionary new supplement system HydroxyBMD 3 at the National [...]

Best SARMs for Bulking, Cutting, Fat Loss & Muscle Growth: Top Selective Androgen Receptor Modulators Reviewed for Lean Gains & Shredded Physique From CrazyBulk

25/04/2025 - 18:36

Discover the best SARMs for bulking, cutting, fat loss, and muscle growth in 2025. Boost strength, shred fat, and enhance performance naturally with powerful, legal SARMs alternatives. New York City, April 25, 2025 ( [...]

Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025

25/04/2025 - 19:00

CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug delivery platform, announced today the [...]

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

25/04/2025 - 19:00

Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour BRAF degrader demonstrates broad activity across all three BRAF [...]

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

25/04/2025 - 19:00

BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory [...]

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170

25/04/2025 - 19:00

Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- IO Biotech ( [...]

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting

25/04/2025 - 19:00

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 [...]

T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy

25/04/2025 - 19:00

– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep [...]

Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025

25/04/2025 - 19:00

Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value [...]

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

25/04/2025 - 19:00

Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancer Patient recruitment ongoing in Phase 1 [...]

Avis aux médias - Exposition Réalité Virtuelle 2025 : Accélérer l'innovation en matière de soins de santé

25/04/2025 - 13:30

MONTRÉAL, 25 avr. 2025 (GLOBE NEWSWIRE) -- Les représentants des médias sont cordialement invités à l’édition 2025 de la RV Expo : accélérer l’innovation en matière de soins de santé, un événement immersif qui explore [...]